BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28341494)

  • 1. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer.
    Lamers RE; Cuypers M; de Vries M; van de Poll-Franse LV; Ruud Bosch JL; Kil PJ
    Urol Oncol; 2017 Feb; 35(2):37.e9-37.e17. PubMed ID: 28341494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.
    van Tol-Geerdink JJ; Willem Leer J; Weijerman PC; van Oort IM; Vergunst H; van Lin EN; Alfred Witjes J; Stalmeier PF
    BJU Int; 2013 Apr; 111(4):564-73. PubMed ID: 22882966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating preferences for treatments in patients with localized prostate cancer.
    Ávila M; Becerra V; Guedea F; Suárez JF; Fernandez P; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Cunillera O; Pardo Y; Cots F; Ferrer M;
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):277-87. PubMed ID: 25491504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in treatment choices between prostate cancer patients using a decision aid and patients receiving care as usual: results from a randomized controlled trial.
    Lamers RED; Cuypers M; de Vries M; van de Poll-Franse LV; Bosch JLHR; Kil PJM
    World J Urol; 2021 Dec; 39(12):4327-4333. PubMed ID: 34272972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of an online support group on patients׳ treatment decisions for localized prostate cancer: An online survey.
    Huber J; Maatz P; Muck T; Keck B; Friederich HC; Herzog W; Ihrig A
    Urol Oncol; 2017 Feb; 35(2):37.e19-37.e28. PubMed ID: 27810256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early prostate cancer--which treatment do men prefer and why?
    Anandadas CN; Clarke NW; Davidson SE; O'Reilly PH; Logue JP; Gilmore L; Swindell R; Brough RJ; Wemyss-Holden GD; Lau MW; Javle PM; Ramani VA; Wylie JP; Collins GN; Brown S; Cowan RA;
    BJU Int; 2011 Jun; 107(11):1762-8. PubMed ID: 21083643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of patient education materials for the "German Prostate Cancer Trial PREFERE"].
    Sänger S; Wiegel T; Stöckle M; Härter M; Bergelt C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(1):28-39. PubMed ID: 25839363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.
    Hall JD; Boyd JC; Lippert MC; Theodorescu D
    Urology; 2003 Feb; 61(2):402-7. PubMed ID: 12597956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a decision aid on newly diagnosed prostate cancer patients' understanding of the rationale for active surveillance.
    Formica MK; Wason S; Seigne JD; Stewart TM
    Patient Educ Couns; 2017 May; 100(5):812-817. PubMed ID: 27923674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer.
    Smith AB; Mancuso P; Sidhom M; Wong K; Berry M; Rincones O; Forstner D; Bokey L; Girgis A
    BMJ Open; 2017 Nov; 7(11):e018403. PubMed ID: 29102996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision-making processes among men with low-risk prostate cancer: A survey study.
    Hoffman RM; Van Den Eeden SK; Davis KM; Lobo T; Luta G; Shan J; Aaronson D; Penson DF; Leimpeter AD; Taylor KL
    Psychooncology; 2018 Jan; 27(1):325-332. PubMed ID: 28612468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Preferences of Patients With Benign Prostatic Hyperplasia Before and After Using a Web-based Decision Aid.
    Lamers RED; van der Wijden FC; de Angst IB; de Vries M; Cuypers M; van Melick HHE; de Beij JS; Oerlemans DJAJ; van de Beek K; Bosch RJLHR; Kil PJM
    Urology; 2020 Mar; 137():138-145. PubMed ID: 31899227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
    Bosco JL; Halpenny B; Berry DL
    Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: Results from the PROFILES registry.
    Cuypers M; Lamers RED; de Vries M; Husson O; Kil PJM; van de Poll-Franse LV
    Urol Oncol; 2016 Nov; 34(11):482.e11-482.e18. PubMed ID: 27432432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment decision-making strategies and influences in patients with localized prostate carcinoma.
    Gwede CK; Pow-Sang J; Seigne J; Heysek R; Helal M; Shade K; Cantor A; Jacobsen PB
    Cancer; 2005 Oct; 104(7):1381-90. PubMed ID: 16080181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care.
    Johnson DC; Mueller DE; Deal AM; Dunn MW; Smith AB; Woods ME; Wallen EM; Pruthi RS; Nielsen ME
    J Urol; 2016 Dec; 196(6):1640-1644. PubMed ID: 27346032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancer.
    Mazur DJ; Merz JF
    J Am Geriatr Soc; 1996 Aug; 44(8):934-7. PubMed ID: 8708303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
    O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
    Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.